» Articles » PMID: 15159056

Mannan-binding Lectin--a Soluble Pattern Recognition Molecule

Overview
Journal Mol Immunol
Date 2004 May 26
PMID 15159056
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The immune system must discriminate between self and non-self. Mannan-binding lectin (MBL) is a recognition molecule able to differentiate between the carbohydrates found on self glycoproteins and the carbohydrate patterns found on infectious non-self surfaces. It exists in a complex with MBL-associated serine proteases (MASPs). When MBL binds to suitable carbohydrate pattern it causes activation of MASPs leading to triggering of the complement cascade. This results in limiting the infection and the orchestration of subsequent adaptive immune response. The plasma concentration of MBL is determined by genetic polymorphisms. Deficiency of MBL is a risk factor for infection, especially when other functions in the immune system are also compromised. MBL has a potential to react against altered-self structures, as found on apoptotic cells, cancers or ischemic-reperfused tissue. The focus of the current review is to summarize the recent progress in our understanding of MBL functions.

Citing Articles

Recognition of by the pattern recognition molecules langerin, mannan-binding lectin, and surfactant protein D: the influence of capsular polysaccharides and wall teichoic acid.

Hymoller K, Christiansen S, Schlosser A, Skov Sorensen U, Lee J, Thiel S Front Immunol. 2025; 15:1504886.

PMID: 39850879 PMC: 11756514. DOI: 10.3389/fimmu.2024.1504886.


High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes.

Dorflinger G, Hoyem P, Laugesen E, Ostergaard J, Funck K, Steffensen R Front Immunol. 2023; 13:1080388.

PMID: 36618347 PMC: 9816478. DOI: 10.3389/fimmu.2022.1080388.


The Complement System, Aging, and Aging-Related Diseases.

Zheng R, Zhang Y, Zhang K, Yuan Y, Jia S, Liu J Int J Mol Sci. 2022; 23(15).

PMID: 35955822 PMC: 9369321. DOI: 10.3390/ijms23158689.


Mechanism-Based Biomarker Prediction for Low-Grade Inflammation in Liver and Adipose Tissue.

van Bilsen J, van den Brink W, van den Hoek A, Dulos R, Caspers M, Kleemann R Front Physiol. 2021; 12:703370.

PMID: 34858196 PMC: 8631400. DOI: 10.3389/fphys.2021.703370.


The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease.

Tan S, Snelson M, Ostergaard J, Coughlan M Antioxid Redox Signal. 2021; 37(10-12):781-801.

PMID: 34806406 PMC: 9587781. DOI: 10.1089/ars.2021.0125.